The Patent Finder

Pepscan Systems B.V.

Also on record
Records under this name other than patents Pepscan Systems B.V. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.

Back to Pepscan Systems B.V.

PatentTitleStatus Expires Confidence
US 8,742,070Method for selecting a candidate drug compound
Term ended
Ended no later than Feb 26, 2024 · From the USPTO record
Term endedEnded no later than Feb 26, 2024From the USPTO record
US 8,748,105Method for selecting a candidate drug compound
Term ended
Term ended Feb 26, 2024 · From the USPTO record
Term endedTerm ended Feb 26, 2024From the USPTO record
US 9,176,127Method for selecting a candidate drug compound
Term ended
Ended no later than Feb 26, 2024 · From the USPTO record
Term endedEnded no later than Feb 26, 2024From the USPTO record
US 8,772,236Truncated Cystine-Knot Proteins
Formerly held
Lapsed on the fee record
Ended Jul 8, 2022 · High confidence
Lapsed on the fee recordEnded Jul 8, 2022High confidence
US 7,863,239Binding compounds, immunogenic compounds and peptidomimetics
Lapsed on the fee record
Ended Jan 4, 2019 · From the USPTO record
Lapsed on the fee recordEnded Jan 4, 2019From the USPTO record
US 7,361,349Peptide, immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
Term ended
Term ended Apr 28, 2016 · From the USPTO record
Term endedTerm ended Apr 28, 2016From the USPTO record
US 7,972,993Identification of protein binding sites
Lapsed on the fee record
Ended Jul 5, 2015 · From the USPTO record
Lapsed on the fee recordEnded Jul 5, 2015From the USPTO record
US 6,761,890Peptide, immunogenic composition and vaccine or medical preparation, a method to immunize animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
Term ended
Term ended Jun 7, 2015 · From the USPTO record
Term endedTerm ended Jun 7, 2015From the USPTO record
US RE39,048Peptide, immunogenic composition and vaccine or medical preparation, a method to immunise animals against the hormone LHRH, and analogs of the LHRH tandem repeat peptide and their use as vaccine
Term ended
Term ended Jun 7, 2015 · From the USPTO record
Term endedTerm ended Jun 7, 2015From the USPTO record
US 7,435,721Transport peptides such as C-terminal Erns peptide and analogues thereof
Lapsed on the fee record
Ended Oct 14, 2012 · From the USPTO record
Lapsed on the fee recordEnded Oct 14, 2012From the USPTO record
10 of 13 patents shown.
Pro members see all 13.
Pro members: see all 13 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited